Zobrazeno 1 - 10
of 68
pro vyhledávání: '"R. Coldewey"'
Publikováno v:
European Journal of Haematology. 54:137-146
A total of 153 diagnostic bone marrow biopsies from patients with advanced stages of multiple myeloma corresponding to stages II and III according to the Durie/Salmon classification were evaluated prior to any treatment in a prospective therapy trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e1d45444724ea56424363941537210
https://doi.org/10.1111/j.1600-0609.1995.tb00204.x
https://doi.org/10.1111/j.1600-0609.1995.tb00204.x
Autor:
R. Leo, B. R. Suchy, J. Oertel, J. Währisch, Helmuth Deicher, M. Planker, C.-H.-R. Hauswaldt, K. Görg, A. Georgii, C. Tirier, H. Gamm, J. Karow, K. Schumacher, M. Sailer, H.J. Keyserlingk, R. Coldewey, M. Gramatzki, D. Peest, Volker Diehl, H. M. Reinold, A. Kindler, V. Hiemeyer, U. Essers, E. Schäfer, C. Vykoupil, E. Hoeppner, S. Glück, D. Urbanitz, E. Heilmann
Publikováno v:
European Journal of Cancer. 29:978-983
Follow-up data of 320 multiple myeloma (MM) patients entering the German Myeloma Treatment Group (GMTG) trial MM01 were analysed for factors predicting overall (OAS) and tumour related survival (TRS). Response to primary induction chemotherapy was re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03ccf0bd6b2ba9c148f3fdcc3cd664a
https://doi.org/10.1016/s0959-8049(05)80205-9
https://doi.org/10.1016/s0959-8049(05)80205-9
Autor:
H. Ehrfeld, Seelig Hp, R. Coldewey, D. Schendel, H J Lakomek, F. Krapf, K. Hartung, B. Lang, Müller R, H. Deicher
Publikováno v:
Rheumatology International. 11:243-249
Antibodies against Ro and La, including recombinant La and recombinant 60 kD-Ro, were determined by counter immunoelectrophoresis and ELISA in over 300 central European systemic lupus erythematosus (SLE) patients. The presence of both Ro and La antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26a49b897240ff57ed5357ab92178ca9
https://doi.org/10.1007/bf00301501
https://doi.org/10.1007/bf00301501
Autor:
A. Corvetta, D. Schendel, W. Stangel, B. Liedvogel, H. Deicher, F. Krapf, Ch. Specker, H.-J. Lakomek, B. Lang, H H Peter, R. Coldewey, K. Hartung, J. R. Kalden
Publikováno v:
Autoimmunity. 13:95-99
Anticardiolipin antibodies (aCL) and HLA-DR antigens were determined in 314 central European patients with systemic lupus erythematosus (SLE). Both HLA-DR4 and DR7 were increased in aCL-positive patients, and aCL were significantly associated with DR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a099cfad10bac8fd4c51de9c2f88ff
https://doi.org/10.3109/08916939209001909
https://doi.org/10.3109/08916939209001909
Autor:
G. G. de Lange, W. Stangel, D. Schendel, K Pirner, S Stannat-Kiessling, R. Coldewey, E. Röther, C Specker, K. Hartung
Publikováno v:
Rheumatology International. 11:179-182
Immunoglobulin heavy chain (G1m, G2m, G3m, A2m) and kappa light chain (Km) allotype and phenotype frequencies of 323 central European Caucasian patients with systemic lupus erythematosus (SLE) were examined and correlated with various genetic, serolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0edfbb87d392c27beefb3c3f224d0777
https://doi.org/10.1007/bf00332558
https://doi.org/10.1007/bf00332558
Autor:
D. Schendel, W. Stangel, R. Coldewey, F. Krapf, K. Hartung, Helmuth Deicher, S A Seuchter, Peter M. Schneider, E. D. Albert, B. Lang. Ch. Specker
Publikováno v:
Tissue Antigens. 38:165-168
An analysis of HLA class II antigens in 356 white patients with systemic lupus erythematosus (SLE) showed that all HLA-DR and -DQ homozygous and heterozygous combinations appear with frequencies expected from the observed gene frequencies. HLA-DR2 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fcf8f99a1be574d8ae9c918d45eea89
https://doi.org/10.1111/j.1399-0039.1991.tb01890.x
https://doi.org/10.1111/j.1399-0039.1991.tb01890.x
Autor:
Helmuth Deicher, M. J. Muller, I. Schedel, R. Coldewey, L. Hoogestraat, U. Süttmann, J. Ockenga
Publikováno v:
Klinische Wochenschrift. 69:156-162
Study objective: To determine forms of malnutrition and basal metabolism at different stages of immunological impairment in clinically stable patients infected with Human Immunodeficiency Virus (HIV).Design: Cross sectional study.Setting: 53 outpatie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26046ce5b7741ad196d251e17dbce06d
https://doi.org/10.1007/bf01665858
https://doi.org/10.1007/bf01665858
Autor:
H. Ludwig, K. Havemann, K. Pollow, B. Kornhuber, G. Maschmeyer, M.E. Heim, H. Deicher, W. Hiddemann, H. Wilke, L. Hoffmann, F. Overkamp, K. Lennert, R. Waldmann, M.v. Bülow, H. Gisslinger, H. Köppler, W. Bätz, H. Stein, A. Grothey, E. Fritz, U. Cammerer, M. Fritz, H. Flechtner, J. Stirbu, S. Kunz, D.K. Hossfeld, L. Edler, G.v. Ingersleben, D. Schmähl, C. Gropp, S. Verhees, W. Queißer, M.R. Berger, E. Busse, R. Herrmann, J. Selbach, P. Drings, S. Oehl, H. Konyar, U. Bruntsch, D. Hossfeld, I.-M. v. Broen, R. Holle, V. Cour, H. Link, D. Adam, F. Trux, A. Sinop, H. Kuhn, W. Zeller, E.U. Steinhauer, E. Neeser, B. Steinke, P. Unterburger, K. Schumacher, J.P. Obrecht, B. Mentges, P. Preusser, H. Langenbahn, R. Coldewey, M. Fink, A. Ganser, E. Lötzke, J. Hartlapp, R. Pfab, K. Höffken, M. Flasshove, M. Helmerking, H. J. Schmoll, D. Peest, W. Noder, H. Kotzmann, D. Hoelzer, H.O. Klein, E.D. Kreuser, H.H. Goßmann, H.J. Weh, H.-J. Grill, H. Ehrhart, R. Hein, K.H. Pflüger, C.N. Gutt, E. Heidemann, I. Eschenbach, K. Possinger, P. Meyer
Publikováno v:
Oncology Research and Treatment. 13:57-60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a3331db1962955371764c52860abd3c
https://doi.org/10.1159/000216722
https://doi.org/10.1159/000216722
Autor:
M. Gramatzki, J.T. Fischer, I.-M. von Broen, R. Henke, J. Oertel, E. Schäfer, J. Selbach, R. Coldewey, H. Wagner, R. Hein, H. J. Braun, Deicher H, D. Peest, M. Planker, C. Tirier, R. Leo, H. Bartels, W. Stenzinger, C.R. Meier, E. Schumacher, L. Hoffmann, M. Stennes, K. Schumacher, E. D. Kreuser, W. D. Maier, J. Wysk, R. Bartl, H. J. Weh, H.M. Reinhold
Publikováno v:
Oncology Research and Treatment. 13:458-460
277 untreated multiple myeloma patients of stage I (n = 33), II (n = 106) and III (n = 138) entered the study. Patients of stage II presenting a progressive tumor (n = 64) initially or during observat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::450d7fe7266909265fbcef22491e1292
https://doi.org/10.1159/000216820
https://doi.org/10.1159/000216820
Autor:
B. Göbel, H. Bartels, K. Schumacher, M. Petit, W. Stenzinger, W. D. Maier, L. Hoffmann, P. Harms, C. Platzeck, J. Wysk, M. Planker, R. Leo, R. Bartl, H. Wagner, P. Von Wussow, R. Coldewey, W. Fett, D. Peest, E. D. Kreuser, J.T. Fischer, R. Henke, J. Oertel, Carl Richard Meier, M. Respondek, M. Stennes, C. Tirier, E. Schäfer, H. J. Braun, H. J. Weh, H. Deicher
Publikováno v:
European journal of cancer (Oxford, England : 1990). (2)
406 untreated multiple myeloma patients of stage I (n = 54), II (n = 148) and III (n = 204) were enrolled in the trial. 51/54 stage I and 60/148 stage II patients were asymptomatic and followed without treatment until disease progression (progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa25e7aa87c13ba40e169ecd4a80746
https://pubmed.ncbi.nlm.nih.gov/7718318
https://pubmed.ncbi.nlm.nih.gov/7718318